Assessing the effect of Kankola in hypertension

Pharmaco-therapeutic effect of Kankola (Piper cubeba Linn.f.)Phala in the management of Uchcha-raktchap (Hypertension)

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068843

Enrollment

Registered

2024-06-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group 35- 60 years of age. 2. Patient having symptoms of continuous raised blood pressure. 3.Patient having Systolic blood pressure between 140 to 160mm of Hg and Diastolic blood pressure between 90-100mm of Hg.

Exclusion criteria

Exclusion criteria: 1. Age less than 35 years and more than 60 years of age. 2. Patients having Systolic blood pressure =140 and =160 mm of Hg and Diastolic blood pressure =90 and =100mm of Hg. 3. Pregnant women and lactating mother. 4. Patients receiving on anti hypertensive drug. 5. Complicated hypertensive cases e.g. Nephropathy and left ventricular hypertrophy, heart block , congestive heart failure, coronary artery disease and retinopathy.

Design outcomes

Primary

Measure	Time frame
Changes in blood pressure will be assessed.Timepoint: 60 days	—

Secondary

Measure	Time frame
Changes in 1. RFT/KFT 2. CBC 3. Lipid Profile ( HDL, LDL, VLDL, TG) 4. ECG Timepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Rajendra Prasad Purvia

Post Graduate Institute of Ayurveda DSRRAU Jodhpur

gprachigoyal929@gmail.com9460754660

Outcome results